90 related articles for article (PubMed ID: 10202439)
1. [Proteases and protease inhibitors in the treatment of cancer].
Brünner NA
Ugeskr Laeger; 1999 Mar; 161(11):1577-80. PubMed ID: 10202439
[No Abstract] [Full Text] [Related]
2. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
Fröhlich E
Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
[No Abstract] [Full Text] [Related]
3. Suicidal tumor proteases.
Sloane BF
Nat Biotechnol; 1996 Jul; 14(7):826-7. PubMed ID: 9631001
[No Abstract] [Full Text] [Related]
4. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
5. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitors: a panacea?
Haq SK; Rabbani G; Ahmad E; Atif SM; Khan RH
J Biochem Mol Toxicol; 2010; 24(4):270-7. PubMed ID: 20135636
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors: role and potential therapeutic use in human cancer.
DeClerck YA; Imren S
Eur J Cancer; 1994; 30A(14):2170-80. PubMed ID: 7857719
[TBL] [Abstract][Full Text] [Related]
8. Current status of tissue kallikrein inhibitors: importance in cancer.
Bhoola KD; Misso NL; Naran A; Thompson PJ
Curr Opin Investig Drugs; 2007 Jun; 8(6):462-8. PubMed ID: 17621876
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical studies of MMP inhibitors in cancer.
Drummond AH; Beckett P; Brown PD; Bone EA; Davidson AH; Galloway WA; Gearing AJ; Huxley P; Laber D; McCourt M; Whittaker M; Wood LM; Wright A
Ann N Y Acad Sci; 1999 Jun; 878():228-35. PubMed ID: 10415734
[TBL] [Abstract][Full Text] [Related]
10. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
[TBL] [Abstract][Full Text] [Related]
11. [Proteasome inhibitors--new option in the treatment of tumor diseases].
Spicka I; Klener P
Cas Lek Cesk; 2004; 143(10):701-4. PubMed ID: 15584622
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors as anticancer agents.
Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG
Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645
[TBL] [Abstract][Full Text] [Related]
13. [Antiproteases in the pathogenesis of neoplastic diseases].
Dabrowska M
Przegl Lek; 1998; 55(9):475-9. PubMed ID: 10085727
[TBL] [Abstract][Full Text] [Related]
14. Biologists take degrading route to tackle cancer.
Abbott A
Nature; 2004 Jun; 429(6994):794. PubMed ID: 15215827
[No Abstract] [Full Text] [Related]
15. Proteinase inhibitors in malignancy: therapeutic promise or another white elephant?
Dodwell DJ
J R Soc Med; 1993 Oct; 86(10):573-6. PubMed ID: 8230059
[No Abstract] [Full Text] [Related]
16. Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Levitt NC; Eskens FA; O'Byrne KJ; Propper DJ; Denis LJ; Owen SJ; Choi L; Foekens JA; Wilner S; Wood JM; Nakajima M; Talbot DC; Steward WP; Harris AL; Verweij J
Clin Cancer Res; 2001 Jul; 7(7):1912-22. PubMed ID: 11448904
[TBL] [Abstract][Full Text] [Related]
17. Proteases and protease inhibitors in cancer.
Van Noorden CJ
Acta Histochem; 1998 Nov; 100(4):344-54. PubMed ID: 9842415
[TBL] [Abstract][Full Text] [Related]
18. Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation.
Opdenakker G; Paemen L; Norga K; Masure S
Int J Cancer; 1997 Mar; 70(5):628-30. PubMed ID: 9052766
[No Abstract] [Full Text] [Related]
19. A phase II trial of marimastat in advanced pancreatic cancer.
Evans JD; Stark A; Johnson CD; Daniel F; Carmichael J; Buckels J; Imrie CW; Brown P; Neoptolemos JP
Br J Cancer; 2001 Dec; 85(12):1865-70. PubMed ID: 11747327
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane proteases as disease markers and targets for therapy.
Antczak C; De Meester I; Bauvois B
J Biol Regul Homeost Agents; 2001; 15(2):130-9. PubMed ID: 11501970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]